Literature DB >> 30143813

[High-risk endometrial cancer: In each case an adjuvant radiochemotherapy?]

Felix Bock1, Guido Hildebrandt2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30143813     DOI： 10.1007/s00066-018-1351-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

1.  Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.

Authors:  Marcus E Randall; Virginia L Filiaci; Hyman Muss; Nick M Spirtos; Robert S Mannel; Jeffrey Fowler; J Tate Thigpen; Jo Ann Benda
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

Review 2.  The diagnosis and treatment of endometrial cancer: progress and controversies.

Authors:  Dominik Denschlag; Uwe Ulrich; Günter Emons
Journal:  Dtsch Arztebl Int       Date:  2010-08-29       Impact factor: 5.594

3.  Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.

Authors:  R Maggi; A Lissoni; F Spina; M Melpignano; P Zola; G Favalli; A Colombo; R Fossati
Journal:  Br J Cancer       Date:  2006-07-25       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.